Humetrix and Intel team up on mobile Blue Button app

Given the success of the VA’s Blue Button program, it was only a matter of time before it went mobile.

With the goal of making Blue Button even more convenient, Humetrix recently announced it is working with Intel to demonstrate the new release of its iBlueButton® mobile apps for Intel® Atom™-based Android phones at the HIMSS13 conference and exhibition that has just begun in New Orleans.

According to the company, this latest release of iBlueButton means that consumers who use Intel-based Android smartphones – and soon Intel-powered Android tablets – will be able to securely exchange their medical records with physicians at the point of care, device-to-device, as a way to improve the safety and efficacy of care.

As Mark Blatt, MD, worldwide medical director, sales and marketing group, Intel, put it at the time of the announcement, “Next-generation healthcare delivery requires innovations like the iBlueButton platform, which we are pleased to show on Intel-based Android phones and, later in the year, Intel-based Android tablets. It is designed to allow patients to directly and efficiently access and share their personal health records with their providers using a secure and standardized method.”

iBlueButton is available for iPhone®, iPad® and Android® devices.

In the same announcement, Bettina Experton, MD, President and CEO of Humetrix and Adjunct Professor of Medicine at the University of California San Diego, observed that “iBlueButton’s cross-platform iOS/Android capability lets physicians and patients share medical records and other critical information to improve patient safety and reduce wasteful procedures regardless of whether they use an Android or Apple device.”

The companies’ “dual app system” consists of both a consumer app for iOS or Android smartphones and tablet computers, and the iBlueButton Professional app for physicians, which runs on a tablet. This platform enables the direct and secure transmission of Blue Button and other health records from the patient’s device to their physician’s device.

Leave a Reply

Your email address will not be published. Required fields are marked *